Gastric cancer is a major source of global cancer mortality with limited treatment options and
poor patient survival. As our molecular understanding of gastric cancer improves, we are …

Predictive biomarkers are the mainstay of precision medicine. This review summarizes the
advancements in tissue-based diagnostic biomarkers for gastric cancer, which is considered …

Background & Aims Evidence suggests that a fraction of new gastric cancer cases may be
etiologically associated with Epstein-Barr virus (EBV), a known carcinogenic agent. We …

Introduction: Gastric cancer is among the most common cancers worldwide. Despite
declining incidences, the prognosis remains dismal in Western countries and is better in …

Gastric cancer (GC) pathogenesis is complex and heterogeneous, reflecting morphological,
molecular and genetic diversity. Diffuse gastric cancer (DGC) and intestinal gastric cancer …

Abstract Background Oesophageal (OeC) and gastric (GC) cancer patients are treated with
similar multimodal therapy and have poor survival. There remains an urgent clinical need to …

Genetic analysis and culturing techniques for gastric non-Helicobacter pylori Helicobacter
(NHPH) are progressing. NHPH is reported to accompany nodular gastritis, gastric MALT …

Gastric cancer (GC) is the fifth most common cancer in the world and accounts for 7% of the
total cancer incidence. The prognosis of GC is dismal in Western countries due to late …

Gastric cancer (GC) is the fifth malignancy and the third cause of cancer death worldwide,
according to the global cancer statistics presented in 2018. Its definition and staging have …

Aims Gastric adenocarcinoma with enteroblastic differentiation (GAED) is a rare subset of
alpha‐fetoprotein (AFP)‐producing carcinomas with poor prognosis. However, the …